EyePoint Pharmaceuticals, Inc. Share Agreements
4 Contracts & Agreements
- First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on February 3, 2021)
- Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on January 4, 2021)
- PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on February 8, 2017)
- PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on December 20, 2013)
